METABOLIC N-HYDROXYLATION - USE OF SUBSTITUENT VARIATION TO MODULATE THE INVITRO BIOACTIVATION OF 4-ACETAMIDOSTILBENES

被引：13

作者：

HANNA, PE ^{[1
]}

GAMMANS, RE ^{[1
]}

SEHON, RD ^{[1
]}

LEE, MK ^{[1
]}

机构：

[1] UNIV MINNESOTA,DEPT PHARMACOL,MINNEAPOLIS,MN 55455

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1980年 / 23卷 / 09期

关键词：

D O I：

10.1021/jm00183a014

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1038 / 1044

页数：7

共 31 条

[1]

ARIENS EJ, 1977, DRUG DESIGN ADVERSE, P329

[2]

ARIENS EJ, 1980, DRUG DES, V9, P30

[3] WHAT LIMITS RATE OF AN ENZYME-CATALYZED REACTION [J].

CLELAND, WW .

ACCOUNTS OF CHEMICAL RESEARCH, 1975, 8 (05) :145-151

[4] MIGRATION OF DEUTERIUM DURING HYDROXYLATION OF AROMATIC SUBSTRATES BY LIVER MICROSOMES .I. INFLUENCE OF RING SUBSTITUENTS [J].

DALY, J ;

JERINA, D ;

WITKOP, B .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1968, 128 (02) :517-&

[5]

GAMMANS RE, 1977, DRUG METAB DISPOS, V5, P310

[6]

GAMMANS RE, 1978, DRUG METAB DISPOS, V6, P226

[7] RELATIONSHIP BETWEEN THE LIPID SOLUBILITY OF DRUGS AND THEIR OXIDATION BY LIVER MICROSOMES [J].

GAUDETTE, LE ;

BRODIE, BB .

BIOCHEMICAL PHARMACOLOGY, 1959, 2 (02) :89-96

[8]

HANSCH C, 1973, DRUG METAB REV, V1, P1

[9]

HARFENIST M, J MED CHEM

[10]

HJELMELAND LM, 1977, MOL PHARMACOL, V13, P634

← 1 2 3 4 →